Samuraciclib in combination with fulvestrant in patients with advanced HR+/HER2- breast cancer
Charles Coombes • 8 Dec 2021
Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Keep up to date with all the latest news with our monthly newsletter